Drug-induced lung disease.
D000542:Alveolitis, Extrinsic Allergic / Q000139:chemically induced; D000970:Antineoplastic Agents / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D001986:Bronchial Spasm / Q000139:chemically induced; D004802:Eosinophilia / Q000139:chemically induced; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced; D008168:Lung / Q000473:pathology* / Q000503:physiopathology; D008171:Lung Diseases / Q000139:chemically induced* / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D010243:Paralysis / Q000139:chemically induced; D010996:Pleural Effusion / Q000139:chemically induced; D011650:Pulmonary Alveoli / Q000473:pathology; D011654:Pulmonary Edema / Q000139:chemically induced / Q000503:physiopathology; D011763:Pyrrolizidine Alkaloids / Q000009:adverse effects
D000970:Antineoplastic Agents; D011763:Pyrrolizidine Alkaloids; D001241:Aspirin